Nanoscale · 2023 · 12 citations · 41 references
PharmacyBiotechnologyMolecular PharmaceuticsDrug DeliveryNanobiotechnologyNanoparticle Drug DeliveryDrug Delivery EngineeringDrug EncapsulationNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignDrug Delivery NanocarriersInterferon-stimulated GenesNanocarriersNanoparticlesPh-responsive NanocarriersPh-responsive PolymersPh-responsive SystemsResponsive Nanocarriers
-BMA second block molecular weights of 3, 6, 12, 15, 20, and 30 kDa. All formulations were both pH responsive, endosomolytic, and capable of loading and cytosolically delivering small negatively charged molecules - albeit to different degrees. Using a B16.F10 melanoma model, we showcased the therapeutic potential of a lead FNP formulated PEG-DB nanocarrier, encapsulating the cyclic dinucleotide (CDN) cGAMP to activate the stimulator of interferon genes (STING) pathway in a therapeutically relevant context. Collectively, these data demonstrate that an FNP process can be used to formulate pH-responsive nanocarriers of diverse morphologies using a PEG-DB polymer system. As FNP is an industrially scalable process, these data address the critical translational challenge of producing PEG-DB nanoparticles at scale. Furthermore, the diverse morphologies produced may specialize in the delivery of distinct biomolecular cargos for other therapeutic applications, implicating the therapeutic potential of this platform in an array of disease applications.
41
Shape effects of filaments versus spherical particles in flow and drug delivery
Yan Geng, Paul Dalhaimer, Shenshen Cai et al. · Nature Nanotechnology · 2007 · 2.5K citations · Full text